| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJMOA1800866 |
| P698 | PubMed publication ID | 29526139 |
| P50 | author | Mandeep R. Mehra | Q18720132 |
| P2093 | author name string | Gregory A Ewald | |
| Gabriel Sayer | |||
| Nir Uriel | |||
| Joseph C Cleveland | |||
| Akinobu Itoh | |||
| William G Cotts | |||
| Jerry D Estep | |||
| Yoshifumi Naka | |||
| Carmelo A Milano | |||
| Chetan B Patel | |||
| John B O'Connell | |||
| Ulrich P Jorde | |||
| David Dean | |||
| Melana Yuzefpolskaya | |||
| Valluvan Jeevanandam | |||
| Eric R Skipper | |||
| Mary N Walsh | |||
| Arun Krishnamoorthy | |||
| Poornima Sood | |||
| Sanjeev Gulati | |||
| Daniel J Goldstein | |||
| James W Long | |||
| Brian A Bruckner | |||
| Antone J Tatooles | |||
| Douglas Horstmanshof | |||
| Christopher Salerno | |||
| Gerald Heatley | |||
| MOMENTUM 3 Investigators | |||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart failure | Q181754 |
| P304 | page(s) | 1386-1395 | |
| P577 | publication date | 2018-03-11 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure. | |
| P478 | volume | 378 |
| Q92113333 | 2019 EACTS Expert Consensus on long-term mechanical circulatory support |
| Q64094080 | Acquired von Willebrand Syndrome Associated with Cardiovascular Diseases |
| Q56381075 | Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology |
| Q91841270 | Advances in Clinical Cardiology 2018: A Summary of Key Clinical Trials |
| Q91636257 | Aortic root thrombosis in patients supported with continuous-flow left ventricular assist devices |
| Q89992464 | Atrial Arrhythmias in Patients With Left Ventricular Assist Devices: To Treat or Not to Treat? |
| Q64229620 | Cardiac Assist Devices: Early Concepts, Current Technologies, and Future Innovations |
| Q92300601 | Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology |
| Q91801038 | Comparative Analysis of Established Risk Scores and Novel Hemodynamic Metrics in Predicting Right Ventricular Failure in Left Ventricular Assist Device Patients |
| Q90453517 | Comparing short-term outcome after implantation of the HeartWare® HVAD® and the Abbott® HeartMate 3® |
| Q100401369 | Continuous-flow left ventricular assist devices: Management in the emergency department |
| Q90603121 | CrossTalk proposal: Blood flow pulsatility in left ventricular assist device patients is essential to maintain normal brain physiology |
| Q64051959 | Current perspectives on mechanical circulatory support |
| Q90726839 | Decoupling Between Diastolic Pulmonary Artery and Pulmonary Capillary Wedge Pressures Is Associated With Right Ventricular Dysfunction and Hemocompatibility-Related Adverse Events in Patients With Left Ventricular Assist Devices |
| Q92627959 | Deep Y-Descent in Right Atrial Waveforms Following Left Ventricular Assist Device Implantation |
| Q92589468 | Development of Multidisciplinary Anticoagulation Management Guidelines for Patients Receiving Durable Mechanical Circulatory Support |
| Q88129460 | Device therapy: Superiority of a centrifugal-flow cardiac pump |
| Q93082409 | Do we need aspirin in HeartMate 3 patients? |
| Q64965703 | Does the heart transplant have a future? |
| Q91984579 | Dynamic prediction of left ventricular assist device pump thrombosis based on lactate dehydrogenase trends |
| Q92627082 | Estimation of Central Venous Pressure by Pacemaker Lead Impedances in Left Ventricular Assist Device Patients |
| Q90006143 | Evaluation of in vitro hemolysis and platelet activation of a newly developed maglev LVAD and two clinically used LVADs with human blood |
| Q90215512 | Evolving disruption in left ventricular assist systems: forgiving but not yet forgettable |
| Q92693652 | Exercise training in patients with a left ventricular assist device (Ex-VAD): rationale and design of a multicentre, prospective, assessor-blinded, randomized, controlled trial |
| Q92424968 | Extracorporeal life support to ventricular assist device: potential benefits of sternal-sparing approach |
| Q102145673 | Feasibility of high-intensity interval training in patients with left ventricular assist devices: a pilot study |
| Q90085905 | Gut microbiota, endotoxemia, inflammation, and oxidative stress in patients with heart failure, left ventricular assist device, and transplant |
| Q92669280 | Haemocompatibility-related adverse events are associated with a non-optimal haemodynamic profile during continuous-flow left ventricular assist device support: why it matters |
| Q89606365 | HeartWare Ventricular Assist Device Cannula Position and Hemocompatibility-Related Adverse Events |
| Q90679130 | Highlights from the 2018 American College of Cardiology scientific session in Orlando, Florida |
| Q92454801 | Hurdles to Cardioprotection in the Critically Ill |
| Q94554217 | Improving exercise capacity and quality of life using non-invasive heart failure treatments: evidence from clinical trials |
| Q57462509 | Improving long-term outcomes with left ventricular assist devices-referral, selection, experience, and technology |
| Q90613577 | Interpreting Neurologic Outcomes in a Changing Trial Design Landscape: An Analysis of HeartWare Left Ventricular Assist Device Using a Hybrid Intention to Treat Population |
| Q92625470 | Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical Trial |
| Q64888996 | Left Ventricular Assist Device: What the Internist Needs to Know. A Review of the Literature. |
| Q93057070 | Left Ventricular Assist Devices (LVADS): History, Clinical Application and Complications |
| Q90290987 | Left ventricular assist devices as destination therapy in stage D heart failure |
| Q92645629 | Left ventricular assist devices exchange: why, when and how to do it-experience from experts |
| Q91936365 | Long-Term Left Ventricular Assist Device (LVAD): A Rare Case of 10 Years' Support and Follow-Up |
| Q90566377 | Long-term evaluation of a fully magnetically levitated circulatory support device for advanced heart failure-two-year results from the HeartMate 3 CE Mark Study |
| Q93208675 | Neurological Complications in Patients with Left Ventricular Assist Devices: a Single Institution Retrospective Review |
| Q64115081 | Nine contemporary therapeutic directions in heart failure |
| Q89871702 | Outcome of mechanical circulatory support at the University Medical Centre Utrecht |
| Q89823205 | Outflow graft twisting of Heartmate III left ventricular-assisted device: A case report |
| Q92605869 | Permanent Implantable Cardiac Support Systems |
| Q91988023 | Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure |
| Q89614280 | Physiology of the Assisted Circulation in Cardiogenic Shock: A State-of-the-Art Perspective |
| Q57470879 | Pulmonary function assessment post-left ventricular assist device implantation |
| Q89890409 | Randomized trial of a left ventricular assist device as destination therapy versus guideline-directed medical therapy in patients with advanced heart failure. Rationale and design of the SWEdish evaluation of left Ventricular Assist Device (SweVAD) |
| Q90603187 | Rebuttal from Eric J. Stöhr, Barry J. McDonnell, Paolo C. Colombo and Joshua Z. Willey |
| Q64951626 | Results of concomitant groin-free percutaneous temporary RVAD support using a centrifugal pump with a double-lumen jugular venous cannula in LVAD patients. |
| Q91701605 | Sex Differences in Advanced Heart Failure Therapies |
| Q90633889 | Simulation-Based Mastery Learning Improves Patient and Caregiver Ventricular Assist Device Self-Care Skills: A Randomized Pilot Trial |
| Q64122646 | Structural and functional cardiac profile after prolonged duration of mechanical unloading: potential implications for myocardial recovery |
| Q64233578 | The New Heart Failure Association Definition of Advanced Heart Failure |
| Q64999401 | The evolution of mechanical circulatory support (MCS): a new wave of developments in MCS and heart failure treatment. |
| Q89970206 | Two year adverse outcomes of the magnetic levitated centrifugal continuous flow circulatory pump versus the axial continuous-flow pump for advanced heart failure: A systematic review and meta-analysis of randomized controlled trials |
| Q60928393 | Update on heart failure management and future directions |
| Q60943112 | Updates in heart failure: what last year brought to us |
| Q89522320 | [Diagnostics and treatment of chronic heart failure : Update 2020] |
| Q88598526 | [Percutaneous and surgical options for mechanical circulatory support in treatment of terminal heart failure] |
Search more.